Therapeutic diversity characterizes contemporary prostate cancer management, with treatment selection depending on disease stage, patient characteristics, comorbidities, preferences, and resource availability within healthcare systems. The GCC Prostate Cancer Market Segment stratification by treatment modality includes active surveillance for low-risk disease, radical prostatectomy...